Location History:
- Takasago, JP (2006 - 2011)
- Hyogo, JP (2019 - 2023)
Company Filing History:
5 out of 1,702 
1 out of 95 Years Active: 2006-2023
Title: Mitsuaki Kitano: Innovator in B Cell and Transgenic Cell Production
Introduction
Mitsuaki Kitano is a prominent inventor based in Hyogo, Japan. He has made significant contributions to the fields of immunology and genetic engineering, holding a total of 5 patents. His work focuses on methods for producing B cell populations and transgenic cells, which have important applications in medical research and therapeutic development.
Latest Patents
One of Kitano's latest patents is a method for producing a B cell population that recognizes a specific antigen. This innovative approach involves culturing a cell population comprising B cells with a specific antigen while providing stimulation mediated by CD40 and a BAFF receptor. This method aims to efficiently generate B cells that can target specific antigens, which is crucial for developing effective vaccines and therapies. Another notable patent is a method for producing transgenic cells. This method includes infecting target cells with a virus that carries a chimeric protein and a foreign gene, allowing for the creation of genetically modified cells that can be used in various research and therapeutic applications.
Career Highlights
Throughout his career, Mitsuaki Kitano has worked with notable organizations such as Kaneka Corporation and the Tokyo University of Science Foundation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Kitano has collaborated with esteemed colleagues, including Tomoyuki Nakaishi and Tatsuya Moutai. These partnerships have fostered innovation and have been instrumental in the development of his patented methods.
Conclusion
Mitsuaki Kitano's contributions to the fields of immunology and genetic engineering are noteworthy. His innovative methods for producing B cell populations and transgenic cells have the potential to impact medical research and therapeutic applications significantly. His work exemplifies the importance of innovation in advancing scientific knowledge and improving healthcare solutions.